CX-038839 Omicron (XBB.1.5)
- Generic Name
- CX-038839 Omicron (XBB.1.5)
- Brand Names
- Spikevax
- Drug Type
- Biotech
- CAS Number
- 2918977-08-7
- Unique Ingredient Identifier
- 4F9QRS7ZV2
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 4206
- Registration Number
- NCT06333704
- Locations
- 🇰🇷
Sinsegie ENT Clinic, Busan, Korea, Republic of
🇰🇷Kium Children Hospital, Gunsan, Jeollabuk-do, Korea, Republic of
🇰🇷Jeil Family Medicine Clinic, Gwangju, Korea, Republic of
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 15196685
- Registration Number
- NCT06130345
- Locations
- 🇺🇸
Aetion, Inc, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath